Jun 27, 2014· Comment from American Chemistry Council· FDA-2013-D-1039-0005
Filed on regulations.gov — full text not in the inline record.
FDANonrulemakingFDA-2013-D-1039
Endocrine Disruption Potential of Drugs: Nonclinical Evaluation
RIN
—
Last modified
Sep 9, 2015
Comment window
closed 4634d ago
American Chemistry Council filings
1
Activity
American Chemistry Council filed 1 comment on this docket between Jun 27, 2014 and Jun 27, 2014. 0 other organizations filed here. The comment window closed 4634d ago.
What American Chemistry Council filed (1)
Abstract
No abstract recorded.
View on regulations.gov →Co-filers (0)
See everyone who commented →- American Chemistry CouncilTHIS ORG1 filing · confidence 97%